If you purchased Roundup weed killer before its cancer warning label was added, you may be eligible to receive compensation between $0.50 and $33.00 per bottle under a $45 million class action settlement approved by U.S. District Judge Vince Chhabria. This settlement addresses claims that Monsanto (now owned by Bayer) sold Roundup without adequately warning consumers about potential health risks, allowing customers to unknowingly overpay for unlabeled products.
The settlement covers over 230,000 consumers and represents one of several legal actions against the company over the herbicide’s safety profile. This article explains who qualifies for the Roundup Consumer Overcharge Labeling Class Action Settlement, how much compensation is available, what types of claims are allowed, and what steps you need to take to file. It also covers what makes this settlement different from other Roundup litigation and what rights you retain even after claiming compensation.
Table of Contents
- What Is the Roundup Consumer Overcharge Labeling Class Action Settlement?
- Settlement Amount and Compensation Structure
- Who Can Claim and Eligibility Requirements
- How Much Will Each Claim Be Worth?
- Important Limitations and What the Settlement Doesn’t Cover
- The Bayer Connection and Why This Settlement Exists
- What This Settlement Means for Future Roundup Cases
What Is the Roundup Consumer Overcharge Labeling Class Action Settlement?
The Roundup Consumer Overcharge Labeling class action Settlement (Scott Gilmore et al. v. Monsanto Company, Case No. 3:21-cv-08159, N.D. Cal.) is a federal court-approved agreement in which Bayer agreed to pay up to $45 million to consumers who purchased Roundup products before cancer warning labels were required.
Unlike other Roundup litigation that focuses on personal injury claims from alleged glyphosate exposure, this settlement is specifically about the absence of warning labels at the time of purchase—consumers claim they paid full price for a product that should have carried health warnings from the start. The settlement doesn’t require you to prove you were harmed by Roundup or that you got cancer. Instead, it compensates you simply for purchasing an inadequately labeled product. This makes the claim process much simpler than personal injury litigation. For example, if you bought a 2-liter bottle of Roundup in 2015 when no cancer warning existed on the label, you’re eligible to claim compensation even if you never experienced any health problems. The court found that consumers effectively overpaid because they didn’t have full product information at the time of purchase.
Settlement Amount and Compensation Structure
The total settlement pool is worth up to $45 million, with a minimum guaranteed amount of $23 million. The compensation you receive depends on the size of the Roundup product you purchased and the amount you paid. Class members can claim up to 20% of the average retail price per bottle, with individual claims ranging from $0.50 for the smallest bottles to $33.00 for the largest sizes.
However, the actual amount each claimant receives may be less than the maximum if too many people file claims and the settlement pool doesn’t stretch far enough. The settlement includes no claims processing cap—meaning an unlimited number of consumers can file—but the total payout to claimants cannot exceed the $45 million pool (after attorney fees and other administrative costs are deducted). If more people claim than anticipated, individual awards will be reduced proportionally. Additionally, claimants with proof of purchase can claim unlimited bottles, meaning if you have receipts showing you bought 10 bottles of Roundup, you can file for compensation on all 10 rather than just one claim per household.
Who Can Claim and Eligibility Requirements
You’re eligible to claim if you purchased roundup products in the United States during the relevant time period before the warning labels were required. The eight lead plaintiffs in the case—Scott Gilmore and others—were already compensated directly by the court with $5,000 awards each, plus a total of $210,888 in reimbursement for their litigation expenses. But you don’t need to have been a lead plaintiff to recover; any consumer who bought the product during the eligible period can file a claim.
The key requirement is timing: you must have purchased Roundup before cancer warning labels became mandatory on the packaging. You don’t need to provide a receipt in most cases—the settlement allows people to claim based on reasonable memory of their purchase, which is an important flexibility since many consumers bought these products years ago and may no longer have documentation. However, if you do have proof of purchase (receipts, credit card statements, etc.), you can claim for multiple bottles rather than just one, making it worthwhile to dig through old records or credit card histories if you remember buying Roundup multiple times.
How Much Will Each Claim Be Worth?
Individual claim amounts depend entirely on the product size purchased. Smaller bottles (like 1-ounce or 16-ounce sizes) might result in $0.50 to $5.00 claims, while larger bottles (like 2-liter or gallon-sized containers) could reach the maximum of $33.00 per bottle. The settlement calculates these values as 20% of the average retail price for each product size, so larger bottles naturally generate larger payouts. Here’s a practical example: if you purchased a gallon-sized bottle of Roundup for $25, you could claim $5 (20% of $25).
If you bought three gallon bottles, you could claim $15 total. This compensation isn’t meant to cover your entire purchase price—it’s specifically addressing the overcharge you paid by not having cancer warning information. The comparison to other settlements shows this is relatively modest; many product recall or mislabeling settlements offer much higher per-claim values when they involve actual safety recalls. However, this settlement works in your favor because the claims process is extremely simple—you don’t need medical records, expert testimony, or proof of harm.
Important Limitations and What the Settlement Doesn’t Cover
A critical limitation of this settlement is that it does not resolve personal injury claims. If you believe Roundup actually caused you to develop cancer or suffer other health injuries, this settlement does not prevent you from filing a separate lawsuit or joining another class action for those damages. The court explicitly stated that class members retain their right to pursue cancer or injury claims independently, which means accepting money from this labeling settlement won’t bar you from future litigation if you develop health problems you attribute to glyphosate exposure.
However, if you claim money from this settlement, you should understand what you’re signing up for: you’re receiving compensation for a labeling issue only, not for personal injury. This distinction is crucial because insurance companies and future courts may view your acceptance of settlement money differently than if you had never claimed anything. Additionally, the $5.75 million in attorney fees (reduced from the original $11.25 million request) represents a significant portion of the total settlement, meaning administrative and legal costs will reduce what claimants actually receive. The settlement was approved despite objections that the attorney fees were too high, so if you have concerns about how much of the $45 million actually reaches claimants, that’s a legitimate worry shared by some consumer advocates.
The Bayer Connection and Why This Settlement Exists
Bayer, the German pharmaceutical and chemical company, owns Monsanto and inherited all of its liabilities when it acquired the company for $63 billion in 2018. Roundup is one of the world’s most widely used herbicides, and Monsanto faced numerous lawsuits over the years alleging that glyphosate (Roundup’s active ingredient) causes cancer, particularly non-Hodgkin’s lymphoma.
While those personal injury cases resulted in some high-profile jury verdicts against Bayer, this labeling settlement is separate—it’s about the absence of warnings, not about proving the product is dangerous. The settlement exists because the lawsuit established that Monsanto didn’t include cancer warnings on Roundup labels during the time period covered by the settlement, even though some regulators and scientists were raising concerns about glyphosate’s safety. Whether glyphosate actually causes cancer remains disputed—the EPA still maintains the herbicide is safe at approved use levels—but courts have determined that consumers deserved to know about the debate and concerns so they could make informed purchasing decisions.
What This Settlement Means for Future Roundup Cases
This settlement is specifically about labeling and overcharges, not health claims. If you have a cancer diagnosis you believe is related to Roundup exposure, you have separate legal options that aren’t affected by this settlement. Some consumers have already recovered money in jury trials against Bayer for personal injury, while others are waiting for their cases to proceed through the courts.
This labeling settlement doesn’t prevent you from pursuing health-related claims—in fact, the court included language explicitly preserving your right to do so. Looking forward, this settlement may influence how companies approach product labeling for chemicals with disputed safety profiles. If nothing else, it demonstrates that consumers can recover compensation for being denied information, even if the actual harm from the product itself remains uncertain. For Bayer, settling this labeling dispute while continuing to defend personal injury cases suggests a different risk calculus: the company may have found it cheaper to compensate customers for the lack of warning than to litigate that particular issue in court indefinitely.